Oral cancer: Premalignant conditions and screening - An update

Journal of Cancer Research and Therapeutics

Volumn 8, Issue SUPPL. 2, 2012, Pages

  Nair, Deepa R ^a   Pruthy, Ritesh ^a   Pawar, Uday ^a   Chaturvedi, Pankaj ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Oral cancer; premalignant disorders; screening

Indexed keywords

ACTINIC KERATOSIS; AUTOFLUORESCENCE; CANCER PROGNOSIS; CANCER SCREENING; CHEMOLUMINESCENCE; CIGARETTE SMOKING; CLINICAL PRACTICE; CRYOSURGERY; DISEASE ASSOCIATION; DISEASE SEVERITY; ERYTHROPLASIA; HUMAN; LASER SURGERY; LEUKOPLAKIA; LICHEN PLANUS; MORBIDITY; MOUTH CANCER; MOUTH EXAMINATION; REVIEW; STOMATITIS; TOBACCO DEPENDENCE;

EARLY DETECTION OF CANCER; HUMANS; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS;

EID: 84856937746     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.92217     Document Type: Review

References (94)

1. Barnes L, Eveson JW, Reichart P, Sidransky D. World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours. New Delhi, India: International Agency for Research on Cancer (IARC) IARC Press; 2005. p. 177-9.
2. Warnakulasuriya S, Johnson NW, Van Der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 2007;36:575-80. (Pubitemid 47609807)
3. Petti S. Pooled estimate of world leukoplakia prevalence: A systematic review. Oral Oncol 2003;39:770-80. (Pubitemid 38373461)
4. Mehta FS, Pindborg JJ, Gupta PC, Daftary DK. Epidemiologic and histologic study of oral cancer and leukoplakia among 50,915 villagers in India. Cancer 1969;24:832-49.
5. Bouquot JE. Epidemiology. In: Gnepp DR, editor. Pathology of the head and neck. Philadelphia: Churchill-Livingstone; 1988. p. 263-314.
6. Banoczy J. Follow up studies in oral leukoplakia. J Maxillofac Surg 1977;5:69-75. (Pubitemid 8051313)
7. Bagan JV, Jimenez Y, Murillo J, Gavalda C, Poveda R, Scully C, et al. Lack of association between proliferative verrucous leukoplakia and human papillomavirus infection. J Oral Maxillofac Surg 2007;65:46-9. (Pubitemid 44914028)
8. Hansen LS, Olson JA, Silverman S Jr. Proliferative verrucous leukoplakia. A long-term study of thirty patients. Oral Surg Oral Med Oral Pathol 1985;60:285-98. (Pubitemid 16110465)
9. Cabay RJ, Morton TH Jr, Epstein JB. Proliferative verrucous leukoplakia and its progression to oral carcinoma: A review of the literature. J Oral Pathol Med 2007;36:255-61. (Pubitemid 46632606)
10. van der Waal I, Reichart PA. Oral proliferative verrucous leukoplakia revisited. Oral Oncol 2008;44:719-21. (Pubitemid 351992921)
11. Axell T. Occurrence of leukoplakia and some other oral white lesions among 20,333 adult Swedish people. Community Dent Oral Epidemiol 1987;15:46-51.
12. Mehta FS, Shroff BC, Gupta PC, Daftary DK. Oral leukoplakia in relation to tobacco habits. A ten year follow-up study of Bombay policemen. Oral Surg Oral Med Oral Pathol 1972;34:426-33.
13. Silverman S, Bhargava K, Smith LW, Malaowala AM. Mailgnant transformation and natural history of oral leukoplakia in 57,518 industrial workers of Gujarat, India. Cancer 1976;38:1790-4.
14. Pindborg JJ, Jolst O, Renstrup G, Roed-Petersen B. Studies in oral leukoplakia: a preliminary report on the period prevalence of malignant transformation in leukoplakia based on a follow-up study of 248 patients. J Am Dent Assoc 1968;76:767-71.
15. Einhorn J, Wersall J. Incidence of oral carcinoma in patients with leukoplakia of the oral mucosa. Cancer 1967;20:2189-93.
16. Pindborg JJ, Reichart PA, Smith CJ, van der Waal I. Histological typing of cancer and precancer of the oral mucosa. International histological classification of tumours. 2nd ed. Springer: World Health Organization; 1997.
17. Reichart PA, Philipsen HP. Oral erythroplakia. A review. Oral Oncol 2005;41:551-61.
18. Shafer WG, Waldron CA. Erythroplakia of the oral cavity. Cancer 1975;36:1021-8.
19. Tilakaratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakulasuriya S. Oral submucous fibrosis: Review on aetiology and pathogenesis. Oral Oncol 2006;42:561-8. (Pubitemid 43965004)
20. Pillai R, Balaram P, Reddiar KS. Pathogenesis of Oral Submucous Fibrosis. Cancer 1992;69:2011-7.
21. Pindborg JJ, Mehta FS, Gupta PC, Daftary DK. Prevalence of oral submucous fibrosis among 50,915 Indian villagers. Br J Cancer 1968;22:646-54.
22. Paymaster JC. Cancer of the buccal mucosa: A clinical study of 650 cases in Indian patients. Cancer 1956;9:431-5.
23. Murti PR, Bhonsle RB, Pindborg JJ, Daftary DK, Gupta PC, Mehta FS. Malignant transformation rate in oral submucous fibrosis over a 17-year period. Community Dent Oral Epidemiol 1985;13:340-1.
24. Sugerman PB, Satterwhite K, Bigby M. Autocytotoxic T-cell clones in lichen planus. Br J Dermatol 2000;142:449-56. (Pubitemid 30159066)
25. Sugerman PB, Savage NW, Walsh LJ, Zhao ZZ, Zhou XJ, Khan A, et al. The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 2002;13:350-65. (Pubitemid 36041624)
26. Andreasen JO. Oral lichen planus. 1. A clinical evaluation of 115 cases. Oral Surg Oral Med Oral Pathol 1968;25:31-42.
27. Hsue SS, Wang WC, Chen CH, Lin CC, Chen YK, Lin LM. Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: A follow-up study based in a Taiwanese hospital. J Oral Pathol Med 2007;36:25-9.
28. Mattsson U, Jontell M, Holmstrup P. Oral lichen planus and malignant transformation: Is a recall of patients justified? Crit Rev Oral Biol Med 2002;13:390-6. (Pubitemid 36569343)
29. Roosaar A, Yin L, Sandborgh-Englund G, Nyren O, Axell T. On the natural course of oral lichen lesions in a Swedish population-based sample. J Oral Pathol Med 2006;35:257-61.
30. van der Meij EH, Mast H, Van der Waal I. The possible premalignant character of oral lichen planus and oral lichenoid lesions: A prospective five-year follow-up study of 192 patients. Oral Oncol 2007;43:742-8. (Pubitemid 47259439)
31. Lanfranchi-Tizeira HE, Aguas SC, Sano SM. Malignant transformation of atypical oral lichen planus: A review of 32 cases. Med Oral 2003;8:2-9. (Pubitemid 36150914)
32. Ismail SB, Kumar SK, Zain RB. Oral lichen planus and lichenoid reactions: Etiopathogenesis, diagnosis, management and malignant transformation. J Oral Sci 2007;49:89-106.
33. van der Meij EH, Van der Waal I. Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. J Oral Pathol Med 2003;32:507-12.
34. Larsson A, Warfvinge G. Oral lichenoid contact reactions may occasionally transform into malignancy. Eur J Cancer Prev 2005;14:525-9. (Pubitemid 41689652)
35. Krutchkoff DJ, Eisenberg E. Lichenoid dysplasia: A distinct histopathologic entity. Oral Surg Oral Med Oral Pathol 1985;60:308-15. (Pubitemid 16110467)
36. Mignogna MD, Fedele S, Lo Russo L. Dysplasia/neoplasia surveillance in oral lichen planus patients: A description of clinical criteria adopted at a single centre and their impact on prognosis. Oral Oncol 2006;42:819-24. (Pubitemid 44307762)
37. Pindborg JJ, Mehta FS, Gupta PC, Daftary DK, Smith CJ. Reverse smoking in Andhra Pradesh, India: A study of palatal lesions among 10,169 villagers. Br J Cancer 1971;25:10-20.
38. Ortiz GM, Pierce AM, Wilson DF. Palatal changes associated with reverse smoking in Filipino women. Oral Dis 1996;2:232-7. (Pubitemid 27005101)
39. Glogau RG. The risk of progression to invasive disease. J Am Acad Dermatol 2000;42:23-4.
40. Smith JF, Mincer HA, Hopkins KP, Bell J. Snuff-dipper's lesion. A cytological and pathological study in a large population. Arch Otolaryngol 1970;92:450-456.
41. van der Hem PS, Nauta JM, Van der Wal JE, Roodenburg JL. The results of CO2 laser surgery in patients with oral leukoplakia: A 25 year follow up. Oral Oncol 2005;41:31-7. (Pubitemid 39647117)
42. Vedtofte P, Holmstrup P, Hjorting-Hansen E, Pindborg JJ. Surgical treatment of premalignant lesions of the oral mucosa. Int J Oral Maxillofac Surg 1987;16:656-64. (Pubitemid 18025813)
43. Lodi G, Sardella A, Bez C, Demarosi F, Carrassi A. Interventions for treating oral leukoplakia. Cochrane Database Syst Rev 2006;(4):CD001829.
44. Lodi G, Porter S. Managment of potentially malignant disorders: Evidence and critique. J Oral Pathol Med 2008;37:63-9.
45. Sako K, Marchetta FC, Hayes RL. Cryotherapy of intraoral leukoplakia. Am J Surg 1972;124:482-4.
46. Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer 2003;3:380-7. (Pubitemid 37328858)
47. Kubler A, Haase T, Rheinwald M, Barth T, Muhling J. Treatment of oral leukoplakia by topical application of 5-aminolevulinic acid. Int J Oral Maxillofac Surg 1998;27:466-9. (Pubitemid 128362255)
48. Fan KF, Hopper C, Speight PM, Buonaccorsi G, MacRobert AJ, Bown SG. Photodynamic therapy using 5-aminolevulinic acid for premalignant and malignant lesions of the oral cavity. Cancer 1996;78:1374-83. (Pubitemid 26317856)
49. Sieron A, Adamek M, Kawczyk-Krupka A, Mazur S, Ilewicz L. Photodynamic therapy (PDT) using topically applied g-aminolevulinic acid (ALA) for the treatment of oral leukoplakia. J Oral Pathol Med 2003;32:330-6. (Pubitemid 36781531)
50. Scully C, Bagan J. Oral squamous cell carcinoma overview. Oral Oncol 2009;45:301-8.
51. Wilson JMG, Jungner G. Principles and practice of screening for disease. Geneva: WHO; 1968.
52. Jullien JA, Downer MC, Zakrzewska JM, Speight PM. Evaluation of a screening test for the early detection of oral cancer and precancer. Community Dent Health 1995;12:3-7.
53. Downer MC, Evans AW, Hughes Hallet CM, Jullien JA, Speight PM, Zakrzewska JM. Evaluation of screening for oral cancer and precancer in a company headquarters. Community Dent Oral Epidemiol 1995;23:84-8.
54. Warnakulasuriya KA, Nanayakkara BG. Reproducibility of an oral cancer and precancer detection program using a primary health care model in Sri Lanka. Cancer Detect Prev 1991;15:331-4.
55. Warnakulasuriya S, Pindborg JJ. Reliability of oral precancer screening by primary health care workers in Sri Lanka. Community Dent Health 1990;7:73-9.
56. Mathew B, Sankaranarayanan R, Sunilkumar KB, Kuruvila B, Pisani P, Nair MK. Reproducibility and validity of oral visual inspection by trained health workers in the detection of oral precancer and cancer. Br J Cancer 1997;76:390-4. (Pubitemid 27308092)
57. Mehta FS, Gupta PC, Bhonsle RB, Murti PR, Daftary DK, Pindborg JJ. Detection of oral cancer using basic health workers in an area of high oral cancer incidence in India. Cancer Detect Prev 1986;9:219-25.
58. Downer MC, Moles DR, Palmer S, Speight PM. A systematic review of test performance in screening for oral cancer and precancer. Oral Oncol 2004;40:264-73. (Pubitemid 38121563)
59. Sankaranarayanan R, Mathew B, Jacob BJ, Thomas G, Somanathan T, Pisani P, et al. Early findings from a community-based, clusterrandomized, controlled oral cancer screening trial in Kerala, India. The Trivandrum Oral Cancer Screening Study Group. Cancer 2000;88:664-73. (Pubitemid 30056944)
60. Ramadas K, Sankaranarayanan R, Jacob BJ, Thomas G, Somanathan T, Mahe C, et al. Interim results from a cluster randomized controlled oral cancer screening trial in Kerala, India. Oral Oncol 2003;39:580-8. (Pubitemid 36694482)
61. Kujan O, Glenny AM, Duxbury AJ, Thakker N, Sloan P. Screening programmes for the early detection and prevention of oral cancer. Cochrane Database Syst Rev 2003;4:CD004150.
62. Sankaranarayanan R, Ramadas K, Thomas G, Muwonge R, Thara S, Mathew B, et al. Effect of screening on oral cancer mortality in Kerala, India: A cluster-randomised controlled trial. Lancet 2005;365:1927-33. (Pubitemid 40797502)
63. Brocklehurst P, Kujan O, Glenny AM, Oliver R, Sloan P, Ogden G, et al. Screening programmes for the early detection and prevention of oral cancer. Cochrane Database Syst Rev 2010;(11):CD004150.
64. Subramanian S, Sankaranarayanan R, Bapat B, Somanathan T, Thomas G, Mathew B, et al. Cost-effectiveness of oral cancer screening: Results from a cluster randomized controlled trial in India. Bull World Health Organ 2009;87:200-6.
65. Speight PM, Palmer S, Moles DR, Downer MC, Smith DH, Henriksson M, et al. The cost effectiveness of screening for oral cancer in primary care. Health Technol Assess 2006;10:1-144.
66. Scully C, Malamos D, Levers BG, Porter SR, Prime SS. Sources and patterns of referrals of oral cancer: Role of general practitioners. Br Med J (Clin Res Ed) 1986;293:599-601.
67. Glass RT, Abla M, Wheatley J. Teaching self-examination of the head and neck: Another aspect of preventive dentistry. J Am Dent Assoc 1975;90:1265-8.
68. Scott SE, Grunfeld EA, McGurk M. The idiosyncratic relationship between diagnostic delay and stage of oral squamous cell carcinoma. Oral Oncol 2005;41:396-403. (Pubitemid 40387869)
69. Mathew B, Sankaranarayanan R, Wesley R, Nair MK. Evaluation of mouth self- examination in the control of oral cancer. Br J Cancer 1995;71:397-9.
70. Scott SE, Rizvi K, Grunfeld EA, McGurk M. Pilot study to estimate the accuracy of mouth self-examination in an at-risk group. Head Neck 2010;32:1393-401.
71. Giunta J, Meyer I, Shklar G. The accuracy of the oral biopsy in the diagnosis of cancer. Oral Surg Oral Med Oral Pathol 1969;28:552-6.
72. Eisen D, Frist S. The relevance of the high positive predictive value of the oral brush biopsy. Oral Oncol 2005;41:753-5.
73. Svirsky JA, Burns JC, Carpenter WM, Cohen DM, Bhattacharyya I, Fantasia JE, et al. Comparison of computer-assisted brush biopsy results with follow up scalpel biopsy and histology. Gen Dent 2002;50:500-3.
74. Sciubba JJ. Improving detection of precancerous and cancerous oral lesions. Computer-assisted analysis of the oral brush biopsy. US Collaborative OralCDx Study Group. J Am Dent Assoc 1999;130: 1445-57.
75. Navone R, Burlo P, Pich A, Pentenero M, Broccoletti R, Marsico A, et al. The impact of liquid-based oral cytology on the diagnosis of oral squamous dysplasia and carcinoma. Cytopathology 2007;18:356-60. (Pubitemid 350145650)
76. Fedele S. Diagnostic aids in the screening of oral cancer. Head Neck Oncol 2009;1:5.
77. Bhoopathi V, Kabani S, Mascarenhas AK. Low positive predictive value of the oral brush biopsy in detecting dysplastic oral lesions. Cancer 2009;115:1036-40.
78. Remmerbach TW, Weidenbach H, Pomjanski N, Knops K, Mathes S, Hemprich A, et al. Cytologic and DNA-cytometric early diagnosis of oral cancer. Anal Cell Pathol 2001;22:211-21. (Pubitemid 32960012)
79. Remmerbach TW, Weidenbach H, Muller C, Hemprich A, Pomjanski N, Buckstegge B, et al. Diagnostic value of nucleolar organizer regions (AgNORs) in brush biopsies of suspicious lesions of the oral cavity. Anal Cell Pathol 2003;25:139-46. (Pubitemid 36693700)
80. Remmerbach TW, Meyer-Ebrecht D, Aach T, Wurflinger T, Bell AA, Schneider TE, et al. Toward a multimodal cell analysis of brush biopsies for the early detection of oral cancer. Cancer 2009;117: 228-35.
81. Warnakulasuriya KA, Johnson NW. Sensitivity and specificity of OraScan (R) toluidine blue mouthrinse in the detection of oral cancer and precancer. J Oral Pathol Med 1996;25:97-103. (Pubitemid 126673996)
82. Onofre MA, Sposto MR, Navarro CM. Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:535-40. (Pubitemid 33601661)
83. Martin IC, Kerawala CJ, Reed M. The application of toluidine blue as a diagnostic adjunct in the detection of epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85:444-6. (Pubitemid 128645222)
84. Zhang L, Williams M, Poh CF, Laronde D, Epstein JB, Durham S, et al. Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome. Cancer Res 2005;65:8017-21. (Pubitemid 41297282)
85. Epstein JB, Güneri P. The adjunctive role of toluidine blue in detection of oral premalignant and malignant lesions. Curr Opin Otolaryngol Head Neck Surg 2009;17:79-87.
86. Ram S, Siar CH. Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions. Int J Oral Maxillofac Surg 2005;34:521-7. (Pubitemid 40790349)
87. Farah CS, McCullough MJ. A pilot case control study on the efficacy of acetic acid wash and chemiluminescent illumination (ViziLite) in the visualisation of oral mucosal white lesions. Oral Oncol 2007;43:820-4. (Pubitemid 47259448)
88. Epstein JB, Silverman S Jr, Epstein JD, Lonky SA, Bride MA. Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue. Oral Oncol 2008;44:538-44. (Pubitemid 351681969)
89. Oh ES, Laskin DM. Efficacy of the ViziLite system in the identification of oral lesions. J Oral Maxillofac Surg 2007;65:424-6. (Pubitemid 46329245)
90. Awan KH, Morgan PR, Warnakulasuriya S. Utility of chemiluminescence (ViziLite™) in the detection of oral potentially malignant disorders and benign keratoses. J Oral Pathol Med 2011;40:541-4.
91. Lane PM, Gilhuly T, Whitehead P, Zeng H, Poh CF, Ng S, et al. Simple device for the direct visualization of oral-cavity tissue fluorescence. J Biomed Opt 2006;11:024006.
92. Poh CF, Ng SP, Williams PM, Zhang L, Laronde DM, Lane P, et al. Direct fluorescence visualization of clinically occult high-risk oral premalignant disease using a simple hand-held device. Head Neck 2007;29:71-6. (Pubitemid 46032570)
93. Awan K.H, Morgan P.R, Warnakulasuriya S. Evaluation of an autofluorescence based imaging system (VELscope™) in the detection of oral potentially malignant disorders and benign keratoses. Oral Oncol 2011;47:274-7.
94. Poh CF, Zhang L, Anderson DW, Durham JS, Williams PM, Priddy RW, et al. Fluorescence visualization detection of field alterations in tumor margins of oral cancer patients. Clin Cancer Res 2006;12:6716-22. (Pubitemid 44876840)